急性冠状动脉综合征的抗血栓治疗。
Antithrombotic Therapy in Acute Coronary Syndrome.
机构信息
Hospital Clínic, Cardiovascular Clinic Institute, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain; Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart, Rome, Italy.
Hospital Clínic, Cardiovascular Clinic Institute, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, Barcelona, Spain.
出版信息
Interv Cardiol Clin. 2024 Oct;13(4):507-516. doi: 10.1016/j.iccl.2024.06.005. Epub 2024 Aug 7.
Early mechanical reperfusion, primarily via percutaneous coronary intervention, combined with timely antithrombotic drug administration, constitutes the main approach for managing acute coronary syndrome (ACS). Clinicians have access to a variety of antithrombotic agents, necessitating careful selection to balance reducing thrombotic events against increased bleeding risks. This review offers a comprehensive update on current antithrombotic therapy in ACS, emphasizing the need for individualized treatment strategies.
早期机械再灌注主要通过经皮冠状动脉介入治疗联合及时的抗血栓药物治疗，构成了急性冠状动脉综合征（ACS）的主要治疗方法。临床医生可获得多种抗血栓药物，需要仔细选择以平衡减少血栓事件与增加出血风险。本文全面更新了 ACS 的抗血栓治疗，强调了个体化治疗策略的必要性。
Zotero 插件